Literature DB >> 14745636

Slow progressive FSGS associated with an F392L WT1 mutation.

Petras Kaltenis1, Valérie Schumacher, Augustina Jankauskiene, Arvydas Laurinavicius, Brigitte Royer-Pokora.   

Abstract

Constitutional missense mutations in the WT1 gene are usually associated with the Denys-Drash syndrome, characterized by a rapid progressive nephropathy, male pseudohermaphroditism, and an increased risk for Wilms tumor. We report here a patient with scrotal hypospadias and a slow progressive nephropathy due to focal and segmental glomerulosclerosis. WT1 mutation analysis revealed a constitutional missense mutation in exon 9 resulting in an exchange F392L. This mutation has previously been reported by others in a patient with a similar mild course of nephropathy. In contrast, a mutation in the corresponding codon of exon 8 (F364L) was previously found by us in a patient with a very rapid progression to end-stage renal disease. Whether the position of a mutation may influence the course of the nephropathy must be evaluated in a larger patient cohort. The individual tumor risk for this alteration cannot be given at present because neither of the two patients has shown evidence of a Wilms tumor or a gonadoblastoma to date.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745636     DOI: 10.1007/s00467-003-1372-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

1.  Clinical spectrum of Denys-Drash and Frasier syndrome.

Authors:  S J McTaggart; E Algar; C W Chow; H R Powell; C L Jones
Journal:  Pediatr Nephrol       Date:  2001-04       Impact factor: 3.714

2.  Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations.

Authors:  V Schumacher; K Schärer; E Wühl; H Altrogge; K E Bonzel; M Guschmann; T J Neuhaus; R M Pollastro; E Kuwertz-Bröking; M Bulla; A M Tondera; P Mundel; U Helmchen; R Waldherr; A Weirich; B Royer-Pokora
Journal:  Kidney Int       Date:  1998-06       Impact factor: 10.612

3.  Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.

Authors:  V Schumacher; S Schneider; A Figge; G Wildhardt; D Harms; D Schmidt; A Weirich; R Ludwig; B Royer-Pokora
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease.

Authors:  A Drash; F Sherman; W H Hartmann; R M Blizzard
Journal:  J Pediatr       Date:  1970-04       Impact factor: 4.406

Review 5.  Chronic renal failure and XY gonadal dysgenesis: "Frasier" syndrome--a commentary on reported cases.

Authors:  A V Moorthy; R W Chesney; M Lubinsky
Journal:  Am J Med Genet Suppl       Date:  1987

6.  The nephropathy associated with male pseudohermaphroditism and Wilms' tumor (Drash syndrome): a distinctive glomerular lesion--report of 10 cases.

Authors:  R Habib; C Loirat; M C Gubler; P Niaudet; A Bensman; M Levy; M Broyer
Journal:  Clin Nephrol       Date:  1985-12       Impact factor: 0.975

Review 7.  A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.

Authors:  Rosemary W Heathcott; Ian M Morison; Marie Claire Gubler; Robin Corbett; Anthony E Reeve
Journal:  Hum Mutat       Date:  2002-04       Impact factor: 4.878

Review 8.  Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy?

Authors:  A Koziell; E Charmandari; P C Hindmarsh; L Rees; P Scambler; C G Brook
Journal:  Clin Endocrinol (Oxf)       Date:  2000-04       Impact factor: 3.478

9.  Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.

Authors:  C Jeanpierre; E Denamur; I Henry; M O Cabanis; S Luce; A Cécille; J Elion; M Peuchmaur; C Loirat; P Niaudet; M C Gubler; C Junien
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

Review 10.  The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor.

Authors:  F J Rauscher
Journal:  FASEB J       Date:  1993-07       Impact factor: 5.191

View more
  7 in total

Review 1.  The clinical trial imperative.

Authors:  Debbie Gipson; Howard Trachtman
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

2.  A novel missense mutation of Wilms' Tumor 1 causes autosomal dominant FSGS.

Authors:  Gentzon Hall; Rasheed A Gbadegesin; Peter Lavin; Guanghong Wu; Yangfan Liu; Edwin C Oh; Liming Wang; Robert F Spurney; Jason Eckel; Thomas Lindsey; Alison Homstad; Andrew F Malone; Paul J Phelan; Andrey Shaw; David N Howell; Peter J Conlon; Nicholas Katsanis; Michelle P Winn
Journal:  J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 10.121

3.  WT1 intron 9 splice acceptor site mutation in a 46,XY male with focal segmental glomerulosclerosis.

Authors:  Katsuyoshi Kanemoto; Kenji Ishikura; Daisuke Ariyasu; Yuko Hamasaki; Hiroshi Hataya; Yukihiro Hasegawa; Masahiro Ikeda
Journal:  Pediatr Nephrol       Date:  2006-10-24       Impact factor: 3.714

4.  A novel WT1 gene mutation in a three-generation family with progressive isolated focal segmental glomerulosclerosis.

Authors:  Elisa Benetti; Gianluca Caridi; Cristina Malaventura; Monica Dagnino; Emanuela Leonardi; Lina Artifoni; Gian Marco Ghiggeri; Silvio C E Tosatto; Luisa Murer
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-11       Impact factor: 8.237

5.  A novel WT1 mutation in a 46,XY boy with congenital bilateral cryptorchidism, nystagmus and Wilms tumor.

Authors:  Monica Terenziani; Michele Sardella; Beatrice Gamba; Maria Adele Testi; Filippo Spreafico; Gianluigi Ardissino; Fausto Fedeli; Franca Fossati-Bellani; Paolo Radice; Daniela Perotti
Journal:  Pediatr Nephrol       Date:  2008-12-02       Impact factor: 3.714

6.  Effects on kidney disease, fertility and development in mice inheriting a protein-truncating Denys-Drash syndrome allele (Wt1tmT396).

Authors:  Charles E Patek; David G Brownstein; Stewart Fleming; Caroline Wroe; Lorraine Rose; Anna Webb; Rachel L Berry; Paul S Devenney; Marion Walker; Oliver D K Maddocks; Nicola J Lawrence; David J Harrison; Katrina M Wood; Colin G Miles; Martin L Hooper
Journal:  Transgenic Res       Date:  2007-11-27       Impact factor: 2.788

7.  Spectrum of Clinical Manifestations in Children With WT1 Mutation: Case Series and Literature Review.

Authors:  Patricia Arroyo-Parejo Drayer; Wacharee Seeherunvong; Chryso P Katsoufis; Marissa J DeFreitas; Tossaporn Seeherunvong; Jayanthi Chandar; Carolyn L Abitbol
Journal:  Front Pediatr       Date:  2022-04-15       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.